Constance Protentis, PA
Medical · Neptune, NJNPI 1265921290
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.8% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,524, 2.0 times the $1,258 reported in 2021. Among medical clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 241 payments — averaging $34.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$998
- Abbott$964
- Amgen$782
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$640
- Johnson & Johnson$580
- AstraZeneca$558
- plus $4K from 29 others
What the payments were for
- Travel & lodging$6728%
- Food & beverage$7,52292%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 7 | $998 |
| Abbott | 17 | $964 |
| Amgen | 28 | $782 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $640 |
| Johnson & Johnson | 16 | $580 |
| AstraZeneca | 12 | $558 |
| Novartis | 22 | $455 |
| Kestra Medical Technology Services, Inc. | 14 | $376 |
| Esperion Therapeutics, Inc. | 11 | $340 |
| Cvrx, Inc. | 2 | $292 |
| Merck | 11 | $255 |
| E.r. Squibb & Sons, L.L.C. | 12 | $249 |
| Boehringer Ingelheim | 14 | $224 |
| Pfizer | 12 | $219 |
| Biotronik Inc. | 1 | $144 |
| Bridgebio Pharma, Inc. | 1 | $141 |
| Impulse Dynamics (USA) Inc. | 1 | $132 |
| Shockwave Medical, Inc | 1 | $120 |
| Amarin Pharma, Inc. | 7 | $96 |
| Silk Road Medical, Inc. | 1 | $88 |
| Chiesi USA, Inc. | 5 | $73 |
| Novo Nordisk | 4 | $59 |
| Abiomed | 2 | $54 |
| Lexicon Pharmaceuticals, Inc. | 3 | $53 |
| Stryker | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Atricure, Inc. | 1 | $34 |
| Scpharmaceuticals Inc. | 2 | $31 |
| Boston Scientific | 1 | $29 |
| W. L. Gore & Associates, Inc. | 2 | $28 |
| GE HealthCare | 1 | $27 |
| Cardiovascular Systems Inc. | 2 | $26 |
| Inari Medical, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$503
- CARDIOMEMS$390
- Repatha$388
- XARELTO$339
- Barostim Neo System$292
- OPTIMIZER$264
- VERQUVO$248
- NEXLIZET$226
- NEXLETOL$226
- BioMonitor$144
- Attruby$141
- LEQVIO$135
- FFRangio$134
- CardioMEMS HF System$129
- CAMZYOS$127
- BRILINTA$125
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$120
- WAINUA$119
- Assure WCD$119
- FASENRA$110
How this compares
$8,194 in reported general payments places this provider in the 95th percentile of 573 medical providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 65 | $80,160 |
| EntrestoSacubitril/Valsartan | 16 | $18,314 |
| XareltoRivaroxaban | 16 | $16,750 |
| JardianceEmpagliflozin | 11 | $16,383 |
| BrilintaTicagrelor | 17 | $14,424 |
| FarxigaDapagliflozin Propanediol | 12 | $13,448 |
| Metoprolol Succinate | 69 | $1,314 |
| Atorvastatin Calcium | 54 | $706 |
| ClopidogrelClopidogrel Bisulfate | 51 | $509 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 16 | $442 |
| Amlodipine Besylate | 34 | $395 |
| Losartan Potassium | 34 | $386 |
| Spironolactone | 28 | $338 |
| Potassium Chloride | 24 | $193 |
| Pantoprazole Sodium | 11 | $184 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $219 | $80,16065 claims |
| AstraZenecaBrilinta, Farxiga | $558 | $27,87229 claims |
| NovartisEntresto | $455 | $18,31416 claims |
| Johnson & JohnsonXarelto | $580 | $16,75016 claims |
| Boehringer IngelheimJardiance | $224 | $16,38311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 573 medical providers in New Jersey.
Other medical in Neptune
- Carley PalmerNeptune$6K
- Vincent PolizioNeptune$5K
- Shannon WelnerVerona$176K
- Christinna DelgenioColts Neck$114K
- Anita FoxVerona$17K
- Therese CasasKinnelon$16K
- Joseph CollettiLinwood$16K
- Melissa MiaoKearny$14K
- Gabriela Plesek-AndiaVerona$13K
- Stephanie PhillipsMarlton$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.